Vertex snares $75M windfall in revised CFF deal; Ex-Celgene R&D prez Daniel starts advisory group
Vertex and Cystic Fibrosis Foundation Therapeutics have revised the terms of their collaboration, which will now deliver a $75 million windfall for the biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
